India in trade talks with US, UK and EU. Pharma companies say 'provision for patent holders to extend life of patent on medicine beyond 20 yrs will delay entry of generic medicine'.
In a letter to pharma organisations, govt mentioned a complaint against an event to be held by ‘Indian Psychotropic Society’. Industry members say they have never heard the name.
Drugmakers have also requested the government to consider ‘essentiality’ of the drug, and not its ‘turnover’, as the criterion for inclusion under NLEM.
Proposal for 20 cities is now being fine-tuned. It comes after PMO asked chemicals and fertilisers ministry to draw up a scheme for non-Covid patients.
A report by Hong Kong-based research firm says Indian industries producing anti-HIV, non-steroids based anti-inflammatory drugs are likely to be hit the most.
ThePrint had reported that PM Modi told pharma companies to stop bribing doctors. IPA secy general had said he didn’t have any information about such a meeting.
Rather than functioning as conventional propaganda, the video operates as a device for interpretation, subtly shaping expectations about future developments in China’s naval trajectory.
By pairing Indian drone engineering with Japanese semiconductor expertise, the two firms aim to develop more advanced autonomous systems tailored to both defence & commercial use.
American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.
COMMENTS